Pharmacologic management of nocturnal polyuria: a …
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970679/
WebFeb 2, 2021 · Additionally, several highly selective small-molecule arginine vasopressin 2 receptor agonists are under active development, while appropriately timed short-acting diuretics, pharmacotherapy for hypertension, nonsteroidal anti-inflammatory drugs, and sex hormone replacement therapy are also a focal point of extensive ongoing nocturnal …
DA: 52 PA: 65 MOZ Rank: 98 Up or Down: Up